Physiological Condition Improvement byNCI-TARGET

Improve the chronic hepatitis and reduce the liver damage index of GOT / AST more than 60%

Improve the acute hepatitis and reduce the liver damage index of GPT / ALT more than 55%

Improve the renal function and reduce the production of BUN (blood urea nitrogen) by 64.7%, reduce the generation of gout

PIncrease the platelet count above 60%, reduce the internal bleeding (such as gastric ulcer, bleeding and menstrual bleeding)


Most recent news
In 2004, NCI-TARGET / Treatment has taken out the medical patent of "Anti-cancer Agent" (Anti-tumor Composition) in USA. Its non-toxic anti-cancer effects (LD50 = 4000mg) have been proved by the animal test models separately from the cancer clinical trial and the anti-cancer treatment, and it can be used for clinical purposes or human consumptions. In addition, it is effective for liver function (GOT / AST, GPT / ALT index), renal (BUN, Creatinine index and uric acid gout), long-term stomach pain or hematopoietic function (platelet / white blood cells) and gynecological fields. It is a special medical technology in the world.
NCI-TARGET Efficacy Mechanism
NCI-TARGET Clinical Performance
Improve Your Body
Test Result for Cancer
Who and How Use It
© 2010 NCI target | All right reserved